thalassemia | GenomeWeb

thalassemia

The researchers reported correcting beta thalassemia in a mouse model via a gene editing method delivered by an intravenous injection.

The test uses multicolor high-resolution melt analysis to detect mutations that lead to a potentially fatal blood disorder particularly common in Asian populations.

The center, based in China, will focus on developing products targeting genetic conditions common in Asian populations. 

The group is testing its 42-gene panel on 1,100 individuals, and says it could be better at identifying population-specific variants than current blood typing methods. 

By Adam Bonislawski
Scientists at King’s College London and Guy’s and St Thomas’ NHS Foundation Trust have launched SpotOn Clinical Diagnostics, a firm specializing in mass spec-based diagnosis of hemoglobin disorders.

Scientists from China's Xiamen University and a startup company called Xiamen Zeesan Biotech have submitted the test to Chinese regulatory officials for approval as a widespread prenatal diagnostic and screening tool for β-thalassemia.

Around the Regions

Premium

Obama Ends hESC Research Restrictions, Connecticut Innovations, Helix Therapeutics, Canadian Forest Nanoproducts Network, Québec Consortium for Drug Discovery, Wisconsin Opportunity Grants, Wisconsin Emerging Industries Skills Partnership, Qatar Science & Technology Park

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.